These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
36. [Present status of calcitonin research with special attention to conditions in man]. Sorensen OH; Hindberg I Ugeskr Laeger; 1970 Feb; 132(9):426-9. PubMed ID: 4914424 [No Abstract] [Full Text] [Related]
37. [Clinical and metabolic studies of Paget's bone disease treated with thyrocalcitonin (author's transl)]. Kocián J Cas Lek Cesk; 1981 May; 120(19):571-5. PubMed ID: 7237502 [No Abstract] [Full Text] [Related]
38. [Clinical use of calcitonin]. Rozhinskaia LIa; Marova EI; Zarubina NA; Bukhman AI Probl Endokrinol (Mosk); 1987; 33(5):79-85. PubMed ID: 3321036 [No Abstract] [Full Text] [Related]
39. [Effect of thyrocalcitonin in man]. Haas HG; Dambacher M Schweiz Med Wochenschr; 1968 May; 98(19):727-8. PubMed ID: 5750190 [No Abstract] [Full Text] [Related]
40. [Recent advances on the thyrocalcitonin]. Milhaud G Ann Endocrinol (Paris); 1968; 29(5):563-75. PubMed ID: 4881133 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]